INShore Compared Obinituzumab versus MMF in either FR/SD nephrotic syndrome in kids #ISNWCN
Figure 1 N = 85 #ISNWCN
Table 1 Pretty similar - small differences like this not unexpected in a small trial by chance #ISNWCN
As expected Obinituzumab works #ISNWCN
Secondary outcomes (underpowered) and safety #ISNWCN
The presenters summary #ISNWCN
Kidney Week in Houston: Day 3 — NephJC

Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.

NephJC